Page 59 - IMO-1-1

Innovative Medicines & Omics Antioxidant nanomedicines for therapies

doi: 10.1038/nrcardio.2010.187 doi: 10.1038/s41467-022-34878-2
136. Nienaber CA, Clough RE. Management of acute aortic 148. Xu L, Luo Y, Du Q, et al. Magnetic response combined with
dissection. Lancet. 2015;385(9970):800-811. bioactive ion therapy: A RONS-scavenging theranostic
doi: 10.1016/S0140-6736(14)61005-9 nanoplatform for thrombolysis and renal ischemia-
reperfusion injury. ACS Nano. 2023;17(6):5695-5712.
137. Fan LM, Douglas G, Bendall JK, et al. Endothelial
cell-specific reactive oxygen species production doi: 10.1021/acsnano.2c12091
increases susceptibility to aortic dissection. Circulation. 149. Chandler AB, Chapman I, Erhardt LR, et al. Coronary
2014;129(25):2661-2672. thrombosis in myocardial infarction. Report of a workshop on
doi: 10.1161/CIRCULATIONAHA.113.005062 the role of coronary thrombosis in the pathogenesis of acute
myocardial infarction. Am J Cardiol. 1974;34(7):823-833.
138. Furie B, Furie BC. Mechanisms of thrombus formation.
N Engl J Med. 2008;359(9):938-949. doi: 10.1016/0002-9149(74)90703-6
doi: 10.1056/NEJMra0801082 150. Guo X, Hong T, Zang J, et al. Thrombus-specific/
responsive biomimetic nanomedicine for spatiotemporal
139. Gailani D, Renne T. The intrinsic pathway of coagulation: thrombolysis and alleviation of myocardial ischemia/
A target for treating thromboembolic disease? J Thromb reperfusion injury. J Nanobiotechnology. 2022;20(1):531.
Haemost. 2007;5(6):1106-1112.
doi: 10.1186/s12951-022-01686-1
doi: 10.1111/j.1538-7836.2007.02446.x
151. Firestein GS. Evolving concepts of rheumatoid arthritis.
140. Wendelboe AM, Raskob GE. Global burden of thrombosis: Nature. 2003;423(6937):356-361.
Epidemiologic aspects. Circ Res. 2016;118(9):1340-1347.
doi: 10.1038/nature01661
doi: 10.1161/CIRCRESAHA.115.306841
152. Li RQ, Ma Y, Hong J, Ding Y. Nanoengineered therapy
141. Absar S, Gupta N, Nahar K, Ahsan F. Engineering of aiming at the etiology of rheumatoid arthritis. Nano Today.
plasminogen activators for targeting to thrombus and 2022;42:101367.
heightening thrombolytic efficacy. J Thromb Haemost.
2015;13(9):1545-1556. doi: 10.1016/j.nantod.2021.101367
doi: 10.1111/jth.13033 153. Tardito S, Martinelli G, Soldano S, et al. Macrophage M1/
M2 polarization and rheumatoid arthritis: A systematic
142. Gaffney PJ. Tissue plasminogen activator for thrombolytic review. Autoimmun Rev. 2019;18(11):102397.
therapy: Expectation versus reality. J R Soc Med.
1992;85(11):692-698. doi: 10.1016/j.autrev.2019.102397
doi: 10.1177/014107689208501112 154. Zhu Y, Zhao TJ, Liu M, et al. Rheumatoid arthritis
microenvironment insights into treatment effect of
143. Shi K, Zou M, Jia DM, et al. tPA mobilizes immune cells nanomaterials. Nano Today. 2022;42:101358.
that exacerbate hemorrhagic transformation in stroke. Circ
Res. 2021;128(1):62-75. doi: 10.1016/j.nantod.2021.101358
doi: 10.1161/CIRCRESAHA.120.317596 155. Aletaha D, Smolen JS. Diagnosis and management of
rheumatoid arthritis: A review. JAMA. 2018;320(13):1360-1372.
144. Greer IA. Clinical practice. Pregnancy complicated by
venous thrombosis. N Engl J Med. 2015;373(6):540-547. doi: 10.1001/jama.2018.13103
doi: 10.1056/NEJMcp1407434 156. Yuan F, Quan LD, Cui L, Goldring SR, Wang D.
Development of macromolecular prodrug for rheumatoid
145. Su M, Dai Q, Chen C, Zeng Y, Chu C, Liu G. Nano-medicine arthritis. Adv Drug Deliv Rev. 2012;64(12):1205-1219.
for thrombosis: A precise diagnosis and treatment strategy.
Nanomicro Lett. 2020;12(1):96. doi: 10.1016/j.addr.2012.03.006
doi: 10.1007/s40820-020-00434-0 157. Wang S, Lv J, Meng S, Tang J, Nie L. Recent advances
in nanotheranostics for treat-to-target of rheumatoid
146. Zenych A, Fournier L, Chauvierre C. Nanomedicine arthritis. Adv Healthc Mater. 2020;9(6):e1901541.
progress in thrombolytic therapy. Biomaterials.
2020;258:120297. doi: 10.1002/adhm.201901541
doi: 10.1016/j.biomaterials.2020.120297 158. Ma Y, Lu Z, Jia B, et al. DNA origami as a nanomedicine
for targeted rheumatoid arthritis therapy through
147. Cheng J, Zhang S, Li C, et al. Functionally integrating
nanoparticles alleviate deep vein thrombosis in pregnancy reactive oxygen species and nitric oxide scavenging. ACS
and rescue intrauterine growth restriction. Nat Commun. Nano. 2022;16(8):12520-12531.
2022;13(1):7166. doi: 10.1021/acsnano.2c03991

Volume 1 Issue 1 (2024) 53 doi: 10.36922/imo.2527